MEDICAL DIR-SUB ABUSE SRVS-115

The Medical Director shall be responsible for the overall clinical direction in medical education activities of the Substance Abuse Services (SAS) program.

The Medical Director works closely with medical staff, nursing personnel, OneFifteen and SBHI administration, and nursing administration to fulfill the above responsibilities.  The Medical Director works closely with OneFifteen and SBHI administration in policy formation and program direction.

The Medical Director is responsible for assuring quality patient care provided through the Substance Abuse Services program and assists in maintaining a quality assurance review program for patient care.  He/she will work closely with the OneFifteen and SBHI administration on reviewing and monitoring clinical standards developed for the Substance Abuse Services program.

The Medical Director serves as a liaison between OneFifteen, SBHI, and other health care-related institutions (i.e. OMHAS, ADAMHS) in order to develop strong networking and outreach programs throughout the Dayton area.  He/she will also network with other community entities in order to promote the Substance Abuse Services program’s effectiveness to these institutions.

In an effort to maximize inpatient and outpatient utilization of the Substance Abuse Program program, the Medical Director must be a strong supporter and advocate of OneFifteen by promoting those services to physicians and institutions in the community.

The Medical Director will maintain an active role and stay advised of the activity of the local, regional, state and national organizations and agencies whose activities impact the Substance Abuse Services program and substance abuse in general. This position is comprised of both administrative and clinical responsibilities.

Essential Duties & Functions:

Administrative Duties

• Provide oversight for regulatory and compliance activities. Includes but is not limited to: serving as the responsible person for Ohio Board of Pharmacy TDDD licenses, serving as laboratory director for the CMS CLIA Waiver, and serving as Medical Director for Project DAWN, our Narcan distribution program. 
• Lead implementation of clinical care protocols, care pathways and staffing models in partnership with OneFifteen and SBHI leadership.
• Provide clinical and administrative leadership to medical providers, including physicians, nurse practitioners, and physician assistants. Includes leading the process of hiring medical providers (full-time, part-time, and contract/moonlighting), running provider meetings, and ensuring provider coverage.
• Leads quality and efficiency reviews and process improvement initiatives; provides ongoing, direct feedback to the medical team. 
• Serve as primary collaborating physician for advanced practice providers (NPs and PAs) and oversee and coordinate the training experience for multidisciplinary trainees, including medical residents, into the care delivery experience.

Clinical Care Duties

• Perform functions of a physician within the substance use disorder treatment setting, including timely documentation of clinical encounters.
• Clinical care would be prioritized for the inpatient withdrawal management service (L3.7 care) and crisis stabilization care, though could also include outpatient treatment.
• Interacting face-to-face or via telehealth with patients for purposes of evaluation, treatment planning and discharge planning on a scheduled or unscheduled basis.
• Provide direct clinical oversight for resident physicians and nurse practitioners who are providing direct patient care across treatment services.
• Lead a multidisciplinary team to provide medically informed and evidence-based treatment for individuals with substance use disorders.
• Participate in cross-coverage activities for other medical providers and a rotational on-call service overnight by phone.
• Use technology as provided by SBHI to facilitate a patient’s engagement and participation in care, including use of telehealth for some patient encounters.